Insulin potentiates cytokine-induced VCAM-1 expression in human endothelial cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1782, Issue 9, 2008, Pages 511-516

  Madonna, Rosalinda ^a   Massaro, Marika ^b   De Caterina, Raffaele ^a,b  

^a UNIVERSITY OF CHIETI   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Atherosclerosis; Cytokine; Insulin; Insulin resistance; Type 2 diabetes; Vascular cell adhesion molecule 1

Indexed keywords

CYTOKINE; I KAPPA B ALPHA; INSULIN; LACTACYSTIN; LIPOPOLYSACCHARIDE; PROTEASOME INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROGENESIS; CELL ADHESION; CELL STRAIN U937; CONCENTRATION (PARAMETERS); CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPERINSULINEMIA; INCUBATION TIME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN;

ACETYLCYSTEINE; BLOTTING, NORTHERN; CELL ADHESION; CELLS, CULTURED; CYTOKINES; CYTOSOL; DRUG SYNERGISM; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; INSULIN; LIPOPOLYSACCHARIDES; MONOCYTES; NF-KAPPA B; PHOSPHORYLATION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS; UMBILICAL CORD; VASCULAR CELL ADHESION MOLECULE-1;

EID: 49349104480     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2008.05.006     Document Type: Article

References (32)

1. Fernandez-Real J.M., Vayreda M., Richart C., Gutierrez C., Broch M., Vendrell J., and Ricart W. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J. Clin. Endocrinol. Metab. 86 (2001) 1154-1159
2. Mishima Y., Kuyama A., Tada A., Takahashi K., Ishioka T., and Kibata M. Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 52 (2001) 119-123
3. McMillan D.E. Increased levels of acute-phase serum proteins in diabetes. Metabolism 38 (1989) 1042-1046
4. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., and Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271 (1996) 665-668
5. Paz K., Hemi R., LeRoith D., Karasik A., Elhanany E., Kanety H., and Zick Y. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J. Biol. Chem. 272 (1997) 29911-29918
6. Uysal K.T., Wiesbrock S.M., Marino M.W., and Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389 (1997) 610-614
7. Despres J.P., Lamarche B., Mauriege P., Cantin B., Dagenais G.R., Moorjani S., and Lupien P.J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334 (1996) 952-957
8. Festa A., D'Agostino Jr. R., Howard G., Mykkanen L., Tracy R.P., and Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
9. Soop M., Duxbury H., Agwunobi A.O., Gibson J.M., Hopkins S.J., Childs C., Cooper R.G., Maycock P., Little R.A., and Carlson G.L. Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. Am. J. Physiol. Endocrinol. Metab. 282 (2002) E1276-E1285
10. Golovchenko I., Goalstone M.L., Watson P., Brownlee M., and Draznin B. Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells. Circ. Res. 87 (2000) 746-752
11. Hasan R.N., Phukan S., and Harada S. Differential regulation of early growth response gene-1 expression by insulin and glucose in vascular endothelial cells. Arterioscler Thromb. Vasc. Biol. 23 (2003) 988-993
12. Krogh-Madsen R., Plomgaard P., Keller P., Keller C., and Pedersen B.K. Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E234-E238
13. Dandona P., Aljada A., Mohanty P., Ghanim H., Hamouda W., Assian E., and Ahmad S. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?. J. Clin. Endocrinol. Metab. 86 (2001) 3257-3265
14. Dandona P., Aljada A., and Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 45 (2002) 924-930
15. Dandona P., Aljada A., Dhindsa S., and Garg R. Insulin as an anti-inflammatory and antiatherosclerotic hormone. Clin. Cornerstone Suppl. 4 (2003) S13-S20
16. Dandona P., Chaudhuri A., Mohanty P., and Ghanim H. Anti-inflammatory effects of insulin. Curr. Opin. Clin. Nutr. Metab. Care. 10 (2007) 511-517
17. Iida K.T., Shimano H., Kawakami Y., Sone H., Toyoshima H., Suzuki S., Asano T., Okuda Y., and Yamada N. Insulin up-regulates tumor necrosis factor-alpha production in macrophages through an extracellular-regulated kinase-dependent pathway. J. Biol. Chem. 276 (2001) 32531-32537
18. Madonna R., Pandolfi A., Massaro M., Consoli A., and De Caterina R. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia 47 (2004) 532-536
19. Madonna R., Massaro M., Pandolfi A., Consoli A., and De Caterina R. The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells. Int. J. Immunopathol. Pharmacol. 20 (2007) 539-555
20. Cybulsky M.I., Iiyama K., Li H., Zhu S., Chen M., Iiyama M., Davis V., Gutierrez-Ramos J.C., Connelly P.W., and Milstone D.S. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest 107 (2001) 1255-1262
21. Carluccio M.A., Siculella L., Ancora M.A., Massaro M., Scoditti E., Storelli C., Visioli F., Distante A., and De Caterina R. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 622-629
22. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone Jr. M.A., Shin W.S., and Liao J.K. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96 (1995) 60-68
23. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
24. Old L.J. Tumor necrosis factor. Science 230 (1985) 630-632
25. Gifford G.E., and Lohmann-Matthes M.L. Requirement for the continual presence of lipopolysaccharide for production of tumor necrosis factor by thioglycollate-induced peritoneal murine macrophages. Int. J. Cancer. 38 (1986) 135-137
26. Libby P., Ordovas J.M., Auger K.R., Robbins A.H., and Dinarello C.A. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am. J. Pathol. 124 (1986) 179-185
27. Warner S.J.C., and Libby P. Human smooth muscle cells. Target for and source of tumor necrosis factor. J. Immunol. 142 (1989) 100-109
28. Lee J., and Pilch P.F. The insulin receptor: structure, function, and signaling. Am. J. Physiol. 266 (1994) C319-C334
29. Saad M.F., Knowler W.C., Pettitt D.J., Nelson R.G., Mott D.M., and Bennett P.H. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1 (1989) 1356-1359
30. Jersmann H.P., Hii C.S., Ferrante J.V., and Ferrante A. Bacterial lipopolysaccharide and tumor necrosis factor alpha synergistically increase expression of human endothelial adhesion molecules through activation of NF-kappaB and p38 mitogen-activated protein kinase signaling pathways. Infect. Immun. 69 (2001) 1273-1279
31. Vietor I., Schwenger P., Li W., Schlessinger J., and Vilcek J. Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts. J. Biol. Chem. 268 (1993) 18994-18999
32. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., and Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369 (1994) 156-160